Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001916753 | SCV002196731 | uncertain significance | Progressive sclerosing poliodystrophy | 2022-06-28 | criteria provided, single submitter | clinical testing | This variant, c.116_118del, results in the deletion of 1 amino acid(s) of the POLG protein (p.Gln39del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs763663907, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with POLG-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV003985857 | SCV004113770 | uncertain significance | POLG-related disorder | 2024-02-21 | criteria provided, single submitter | clinical testing | The POLG c.116_118delAGC variant is predicted to result in an in-frame deletion (p.Gln39del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.018% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |